Literature DB >> 23400499

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.

Louisa Kent, Paul Davies, Robin Kennett, Sunil Wimalaratna, Richard Kerr, Martin R Turner, Kevin Talbot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23400499     DOI： 10.1007/s00415-013-6854-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach.

Authors:  M G Winterholler; F J Erbguth; S Wolf; S Kat
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

Review 2.  Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature.

Authors:  T Gioltzoglou; C Cordivari; P J Lee; M G Hanna; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

3.  Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome.

Authors:  F Erbguth; D Claus; A Engelhardt; D Dressler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

4.  Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.

Authors:  E K Tan; Y L Lo; A Seah; A P Auchus
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

Review 5.  Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

Authors:  Beth E Crowner; Diego Torres-Russotto; Alexandre R Carter; Brad A Racette
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

6.  Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.

Authors:  Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-10-16       Impact factor: 3.575

7.  Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.

Authors:  P Girlanda; G Vita; C Nicolosi; S Milone; C Messina
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

Review 8.  Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.

Authors:  Jan-Willem G Meijer; Annet A van Kuijk; Alexander C H Geurts; H Jurgen Schelhaas; Machiel J Zwarts
Journal:  Am J Phys Med Rehabil       Date:  2008-04       Impact factor: 2.159
  8 in total
  2 in total

1.  Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.

Authors:  Juan F Vázquez-Costa; Inmaculada Máñez; Ana Alabajos; Maricruz Guevara Salazar; Cristina Roda; Teresa Sevilla
Journal:  J Neurol       Date:  2016-07-06       Impact factor: 4.849

2.  Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Raph Goldacre; Kevin Talbot; Michael J Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-10       Impact factor: 10.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.